重症监护病房急性肾损伤患者管理中的VExUS评分:AKIVEX研究
这项准实验研究纳入90例重症监护病房发生严重急性肾损伤的患者,干预措施为建议主治医师对VExUS评分>1的患者使用利尿剂,48小时后复查VExUS。VExUS>1组48小时内利尿剂使用率75.0%(27例)高于VExUS≤1组的38.9%(21例),P=0.001;48小时内VExUS评分降低者第28天无肾脏替代治疗天数(28.0;8.0-28.0)显著多于未降低者(15.0;3.0-27.5),P=0.012。
要点
- VExUS评分>1的严重急性肾损伤患者中,48小时内利尿剂使用率为75.0%,高于VExUS≤1者的38.9%。
- 48小时内VExUS评分降低者第28天无肾脏替代治疗天数为28.0天(8.0-28.0),多于未降低者的15.0天(3.0-27.5)。
核心结论
- VExUS评分较高的患者利尿剂使用更多,且48小时内VExUS评分降低与第28天无肾脏替代治疗天数显著增多相关。
研究设计与样本
- 准实验研究,纳入重症监护病房发生的严重急性肾损伤患者90例;干预为建议主治医师对VExUS评分>1的患者使用利尿剂,48小时后复查VExUS;主要结局为第28天无肾脏替代治疗天数。
诊断标准与关键数值
- VExUS评分>1为建议使用利尿剂的阈值;入组时VExUS>1者36例,VExUS≤1者54例。
- VExUS>1组48小时内利尿剂使用率75.0%(27例),VExUS≤1组38.9%(21例),P=0.001。
- 48小时内VExUS评分降低者第28天无肾脏替代治疗天数为28.0天(8.0-28.0),未降低者为15.0天(3.0-27.5),P=0.012。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Venous congestion is a potential cause of acute kidney injury (AKI) and venous excess ultrasound (VExUS) score is a potentially useful tool in this scenario. The aim of this study is to verify whether the VExUS score can serve as a guide to decongestion in patients with severe AKI and whether the modification of the score can be associated with an increase in the number of renal replacement therapy (RRT)-free days in 28 days.
METHODS: This quasi-experimental study was conducted in patients admitted to the intensive care unit who developed severe AKI. The intervention was to suggest to the attending physician the use of diuretic in patients with VExUS >1. After 48 hours, a new VExUS assessment was performed. Primary outcome was RRT-free days at Day 28.
RESULTS: Ninety patients were included. Patients with a VExUS score >1 (n = 36) at enrollment had a greater use of diuretics in the following 48 hours (75.0%, n = 27) than patients with a VExUS ≤1 (n = 54) at enrollment (38.9%, n = 21), P = .001. Patients who reduced the VExUS score had a significantly greater number of RRT-free days at Day 28 (28.0; 8.0-28.0) when compared with those who did not reduce (15.0; 3.0-27.5), P = .012.
CONCLUSIONS: We found a higher diuretic use in patients with a higher VExUS score, and patients who reduced the VExUS in 48 hours had significantly more RRT-free days in 28 days.
引用
- Rihl, Pellegrini, Boniatti, et al. VExUS Score in the Management of Patients With Acute Kidney Injury in the Intensive Care Unit: AKIVEX Study. J Ultrasound Med. 2023. PMID: 37310104. doi:10.1002/jum.16288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。